Dr. Mark Awad
Claim this profileDana Farber Cancer Institute
Area of expertise
Lung Cancer
Mark Awad has run 11 trials for Lung Cancer. Some of their research focus areas include:
Solid Tumors
Mark Awad has run 8 trials for Solid Tumors. Some of their research focus areas include:
Affiliated Hospitals
Dana Farber Cancer Institute
Dana Faber Cancer Institute
Clinical Trials Mark Awad is currently running
APL-101
for Lung Cancer
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Recruiting
1 award
Phase 2
11 criteria
CoREST Inhibitor + Anti-PD-1 Therapy
for Solid Cancers
This trial is testing a new drug, TNG260, combined with an existing cancer treatment, pembrolizumab, in patients with advanced solid tumors that have an STK11 mutation. TNG260 aims to block proteins that help cancer grow, while pembrolizumab boosts the immune system to fight the cancer. Pembrolizumab has been shown to be an effective and safe therapeutic option for various advanced cancers, including endometrial cancer and melanoma. The study will determine the best dose, safety, and effectiveness of this combination.
Recruiting
1 award
Phase 1 & 2
More about Mark Awad
Clinical Trial Related
5 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Mark Awad has experience with
- Carboplatin
- Paclitaxel
- Cisplatin
- Docetaxel
- Nivolumab
- Pemetrexed
Breakdown of trials Mark Awad has run
Lung Cancer
Solid Tumors
Non-Small Cell Lung Cancer
Metastatic Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark Awad specialize in?
Mark Awad focuses on Lung Cancer and Solid Tumors. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Mark Awad currently recruiting for clinical trials?
Yes, Mark Awad is currently recruiting for 4 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Mark Awad has studied deeply?
Yes, Mark Awad has studied treatments such as Carboplatin, Paclitaxel, Cisplatin.
What is the best way to schedule an appointment with Mark Awad?
Apply for one of the trials that Mark Awad is conducting.
What is the office address of Mark Awad?
The office of Mark Awad is located at: Dana Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.